Singapore markets closed

SinoMab BioScience Limited (3681.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.720-0.020 (-1.15%)
At close: 03:55PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-156,163
-243,111
-284,158
-288,194
-122,600
-
Depreciation & amortisation
36,064
36,064
28,033
20,655
10,673
-
Stock-based compensation
18,995
18,995
5,017
62,897
34,903
-
Change in working capital
48,343
48,343
-23,274
46,642
-39,224
-
Other working capital
-291,923
-237,739
-414,919
-361,982
-233,659
-
Other non-cash items
408
408
-4,620
-8,739
-14,930
-
Net cash provided by operating activities
-133,847
-133,847
-300,538
-147,063
-141,338
-
Cash flows from investing activities
Investments in property, plant and equipment
-103,892
-103,892
-114,381
-214,919
-92,321
-
Acquisitions, net
-
-
0
-16,173
-17,332
0
Purchases of investments
-41,000
-41,000
-75,000
-85,000
-69,565
-
Sales/maturities of investments
41,111
41,111
75,566
177,046
0
-
Other investing activities
6,855
6,855
-903
1,344
-
-
Net cash used for investing activities
-96,921
-96,921
-81,358
-137,702
-179,218
-
Net change in cash
-148,501
-148,501
-279,611
-227,250
-339,364
-
Cash at beginning of period
342,887
342,887
562,983
810,370
1,200,868
-
Cash at end of period
203,664
203,664
342,887
562,983
810,370
-
Free cash flow
Operating cash flow
-133,847
-133,847
-300,538
-147,063
-141,338
-
Capital expenditure
-103,892
-103,892
-114,381
-214,919
-92,321
-
Free cash flow
-291,923
-237,739
-414,919
-361,982
-233,659
-